FSA/HSA ELIGIBLE

HOW IT WORKS

Brain health starts one layer earlier.

Subtle sensory shifts appear long before symptoms are obvious. Developed with researchers from Columbia, Johns Hopkins, Harvard, East Anglia and beyond.

16+

PhDs across our research network

400+

Publications from collaborators

2027

Results from our IRB-approved, international, multi-site study

Why the senses? See the evidence →

THE SCIENCE

The brain is only as sharp as its inputs.

Those inputs are the five senses. Medicine has treated the senses as outputs. They are inputs.

LAYER 1 · SENSORY INPUT

Where the signal enters

Smell, taste, hearing, vision, touch. The information the brain runs on.

SuperSenses measures here

LAYER 2 · NEURAL PROCESSING

Where it is carried inward

Integration, activation, network efficiency. The signal moving through the system.

LAYER 3 · COGNITIVE OUTPUT

Where symptoms surface

Memory, attention, executive function. What conventional tests measure.

Where most tools measure

Change often begins at the input. Most assessments only read the output, so by the time they register it, the signal has been shifting for years.

The research behind this layer →

THE EVIDENCE

33%

lower dementia risk with hearing aids

Over seven years, hearing aids were tied to a 33% lower dementia risk, while standard cognitive tests showed no difference between groups.

The change was real before the tests could see it. That interval is the layer sensory measurement follows over time.

Cribb et al., Neurology, 2026.

MEASURE. MANAGE. REPEAT.

How it works, sense by sense.

WHAT THE RESEARCH SHOWS

Changes escape notice, and senses change together.

MEASURE

Measure all five senses.

Smell, taste and touch with the kit. Hearing and vision in the app. 30 min.

Testing smell with the SuperSenses kit and app

WHAT THE RESEARCH SHOWS

In a randomized trial, hearing care improved outcomes.

MANAGE

Act on every result.

Every result comes with a next step, starting at home, with care only if needed. Clinics and communities follow through in the provider dashboard.

SuperSenses app Next Steps screen

WHAT THE RESEARCH SHOWS

A pattern over time says more than one result.

REPEAT

See what changed.

Retest anytime and compare each sense with your last result.

SuperSenses app Sensory Scores screen

WHAT WE MEASURE

Five senses, five specific measurements.

Smell

WHAT WE MEASURE

Naming everyday scents, with 12 smell strips.

WHY IT MATTERS

48 longitudinal studies of 37,783 people link poorer smell with later cognitive decline.

ITS LIMITS

A cold, allergies or sinus trouble can lower a result for reasons unrelated to the brain.

Taste

WHAT WE MEASURE

Naming tastes and rating their strength, with 7 taste strips.

WHY IT MATTERS

Taste is often poorer in people with cognitive disorders, though findings vary more than for smell.

ITS LIMITS

Emerging evidence. Not meaningful on its own.

Touch

WHAT WE MEASURE

Telling one point from two on the fingertip, with a helper.

WHY IT MATTERS

Reduced touch sensitivity has been linked with mild cognitive impairment.

ITS LIMITS

Emerging evidence. Different touch tests measure different things.

Hearing

WHAT WE MEASURE

Tones across pitches in each ear, and hearing in noise.

WHY IT MATTERS

Measured hearing, not self-report, was linked with later dementia. Hearing care slowed decline in a higher-risk group.

ITS LIMITS

Not a clinical hearing exam. Headphones and room noise can affect results.

Vision

WHAT WE MEASURE

Sharpness, color and contrast.

WHY IT MATTERS

A 2024 study linked contrast and near vision, as well as distance acuity, with dementia.

ITS LIMITS

Not an eye exam. It can’t find eye disease.

WHY IT MATTERS

The people who study the senses agree.

“People who have smell and taste issues need care, just like people who have impairments in our other senses, like sight and hearing.”
Dr. Jonathan Overdevest, MD, PhD

Dr. Jonathan Overdevest, MD, PhD

Columbia University. Smell & Taste Center.

VALIDATION EVIDENCE

A longitudinal dataset, benchmarked against clinical gold standards.

Built from repeatable, self-administered testing across all five senses. Assessments developed with PhD researchers across Columbia, Johns Hopkins and Harvard.

Population patterns

Population patterns

Mortality risk rises with severity of sensory changes. Hearing and vision show clear dose-dependent hazard ratios.

Window to change the slope

Window to change the slope

Functional decline modeled with and without early sensory intervention.

Prevalence

Prevalence

Reduced sensory function in our cohort matches rates in large-scale studies (JAMA, Lancet).

Individual sensory tests

Individual sensory tests

Distribution of function across each sense in our cohort.

WHAT WE’VE MADE PRACTICAL

All five senses measured together, in 30 min.

At home, in a clinic or in a community.

A next step for every result.

Repeat anytime, and see change sense by sense.

A provider dashboard for clinics and communities.

WHAT WE’RE STILL ESTABLISHING

How consistent each test is from one session to the next.

Reference ranges by age.

What a change in combined results means.

Whether it improves decisions and outcomes.

This is the work of our clinical validation studies.

What’s established, and what we’re testing →

SCIENTIFIC LEADERSHIP

The researchers and clinicians behind SuperSenses.

Sita Kedia

Sita Kedia, MD, MPH, IFMCP

Preventive Neurology & Brain Health

Dr. Kedia is a triple board-certified neurologist and brain health specialist focused on early, preventive approaches to cognitive change. She works at the intersection of clinical neurology and lifestyle medicine, helping people translate complex neuroscience into everyday decisions.

"Early changes in smell and hearing are often the brain’s first quiet signals that something is shifting. We should be tracking those senses as routinely as blood pressure or cholesterol, and tools like SuperSenses finally make that kind of at-home tracking realistic, so we can pay attention to changes long before more obvious symptoms appear.”

Reza Hosseini

Reza Hosseini Ghomi, MD, MSE

Neuropsychiatry & Brain Health

Dr. Ghomi is a neuropsychiatrist with an engineering background focused on brain health and cognitive aging. His work bridges clinical neuroscience and digital health, with an emphasis on turning early, repeatable signals into practical measurement and decision support over time.

"Earlier measurement improves the quality of downstream decisions."

Vince Bennett

Vince Bennett, MD, FAAEM

Longevity Medicine

Dr. Vince Bennett is a physician focused on longevity medicine and early intervention. His commitment to preventive healthcare aligns with the SuperSenses approach.

Jon Overdevest

Dr. Jon Overdevest, MD PhD

Otolaryngology & Sensory Neuroscience

Dr. Overdevest directs the Smell and Taste Center at Columbia University and is a dual-trained physician-scientist in otolaryngology and sensory neuroscience.

Yangyang Deng

Dr. Yangyang Deng, PhD

Biostatistics & Longitudinal Health Modeling

Dr. Deng is a faculty biostatistician at Johns Hopkins University with deep expertise in longitudinal health modeling, wearable sensor data, and early detection of health change.

Andrea Tales

Andrea Tales, PhD, FBPsS, FLSW

Neuropsychology & Dementia Research

Professor Tales holds a Personal Chair in Neuropsychology & Dementia Research at Swansea University, where she leads work on cognitive aging, attention, and everyday sensory/perceptual change in dementia.

"We’ve underestimated everyday sensory/perceptual change in dementia; aligning rigorous science with practical, scalable tools is the next step.”

Mariano Mastinu

Mariano Mastinu, PhD

Gustatory Assessment & Chemosensation

Dr. Mastinu is a researcher at the Smell & Taste Clinic, Department of Otolaryngology, Universitätsklinikum Carl Gustav Carus, TU Dresden. His work spans gustatory and trigeminal function and clinical strip-based taste assessment.

David Knight

David Knight, BSc(Hons), MCOptom, DipTp(IP)

Clinical Research Optometry

David Knight is an Advanced Clinical Research Optometrist at the Royal Victoria Infirmary in Newcastle, where he delivers ophthalmic research and works across medical retina, cataract, low vision, and paediatric clinics. An independent-prescribing optometrist with a professional certificate in medical retina, he also holds a second honours degree in computing and software engineering.

Carl Philpott

Carl Philpott, MD, FRCS(ORL-HNS)

Rhinology & Olfactology

Professor Philpott holds the Chair of Rhinology & Olfactology at the University of East Anglia and is a Consultant ENT Surgeon, one of the UK's leading authorities on smell and taste. He founded Fifth Sense, the charity for people affected by smell and taste disorders, and directs the UK Smell & Taste Clinics.

See how it runs.

SuperSenses is a measurement and management platform for the five senses and is not a diagnostic instrument.